Trump blasts, to hit domestic drug companies! China will fight back
Medicine Network April 8 News Trump to open fire, to hit the domestic pharmaceutical companies! China fight back, to open!
Trump will impose a tariff, a batch of Chinese medicine guns
On April 4, according to the Xinhua News Agency, the U.S. government issued a list of goods subject to tariffs, which will impose a tariff of 25% on China’s 1,333 U.S. items worth 50 billion U.S. dollars.
The list published by the U.S. Trade Representative’s Office is mostly raw materials that do not directly face consumers. Including chemicals, drug , rubber products, metal products, stainless steel products, aluminum alloy products, turbojet products, light emitting diodes, motorcycles and dental equipment, etc.
According to rough statistics, there are more than 30 pharmaceutical and medical products in the list, including dozens of key products used by US pharmaceutical companies, as well as pacemakers and artificial joints. medical instruments . (See attachments)
Influencing the fate of some raw pharmaceutical companies
The raw material drug is the first. As a raw material export country, according to China medicine Health products According to statistics from the Import and Export Chamber of Commerce, in 2017, China's raw material medicines were exported to 195 countries and regions. India and the United States are important customers. The US imported 3.94 billion US dollars of raw material medicines throughout the year, a year-on-year increase of 23.84%.
11,000 export of bulk drugs enterprise Zhongshi Pharmaceutical Group, Puro Pharmaceuticals, Huahai Pharmaceutical, Chuangnuo Pharmaceutical, China Pharmaceutical, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, Xinhua Pharmaceutical, etc. Attachment)
A year to the United States exports 3.92 billion US dollars, equivalent to more than 20 billion yuan. This is the cumulative amount of exports of many SMEs, some companies only export, several large customers overseas, is likely to be the United States customers, Gao Zheng so much Taxes, export failures, affect fate.
▍U.S.Pharm is even more injured, Trump put it over
However, according to Cypress Blue, many people in the industry saw the above list and expressed that there was no pressure on the company's 'small impact on the company'. The pharmaceutical raw material export leader, ProLogis, said that the company's 2017 raw material drug exports The proportion of the United States only accounted for less than 5% of annual revenue, with little impact; Huahai Pharmaceutical also said that the pressure was not obvious.
On the contrary, the US’s lethality is even greater. A pharmaceutical industry veteran analyzed that raw materials used in the United States were imported mainly from China. The trade war started, and US pharmaceutical companies had a risk of losing food. At least the increase in production costs would probably lead to drugs. The price has risen, and the American health insurance is tight.
If China adopts a counterattack policy and restricts the import of US pharmaceutical preparations, it will even worsen them.
▍ China’s counterattack, also US$50 billion
On the afternoon of the 4th, Xinhua released information on 'China will impose tariffs of 25% on 106 soy airplanes and other commodities in the United States' and announced the list.
Information Display: In order to safeguard China’s own legitimate rights and interests, the Chinese government will, based on the laws and regulations of the Foreign Trade Law of the People’s Republic of China and other basic principles of international law, import agricultural products such as soybeans, automobiles, chemicals, and aircrafts originating in the United States. The tax rate is 25%, and it involves the amount of China’s imports from the United States in 2017 of approximately US$50 billion.
In the list, no pharmaceutical-related products were found.
▍ ▍ 弩 弩, ,, open at any time
The war is not a good thing for anyone. For the pharmaceutical industry, it has little impact on the entire industry, but it will have a great impact on some companies.
U.S. moves, China Sword, but the two sides still have room.
When the United States Government released the list of goods subject to tariffs, it said that there would be 60 days afterwards for the public to give feedback and the government would hold a hearing. On the 4th, Xinhuanet’s counterattack also made it clear that 'the final measure and effective time will be announced separately'.
In the end it will not be played. It seems there is room for maneuver. Even if you go to war, you will accompany him!
